PHAT Q4 2021 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$135,000

Operating Income

-$33M

Net Income

-$36M

EPS (Diluted)

$-0.95

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$42M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$189M

Total Liabilities

$117M

Stockholders' Equity

$72M

Cash & Equivalents

$183M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$135,000	$0	—
Operating Income	-$33M	-$52M	+37.0%
Net Income	-$36M	-$54M	+33.3%